Literature DB >> 20843204

MicroRNA binding site polymorphisms as biomarkers of cancer risk.

Cory Pelletier1, Joanne B Weidhaas.   

Abstract

MicroRNAs (miRNAs) are well established as global gene regulators and thus, slight alterations in miRNA levels as well as their ability to regulate their targets may cause important cellular changes leading to cancer risk. 3´ untranslated region (UTR) miRNA binding site single nucleotide polymorphisms (SNPs) have added another layer of possible genetic variation involved in the complex process of oncogenesis. Identifying these key genetically inherited effectors of miRNA functioning has improved our understanding of the complexity of disease. Interest in the field has grown rapidly in only the last 5 years, with several studies reporting on the role of 3´UTR binding site SNPs as genetic markers of increased cancer susceptibility, as well as biomarkers of cancer type, outcome and response to therapy. Currently, there are numerous known miRNA binding site SNPs associated with multiple cancer subtypes.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20843204      PMCID： PMC3832135          DOI： 10.1586/erm.10.59

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN： 1473-7159            Impact factor:   5.225


  117 in total

1.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

2.  Oral cavity cancer in non-users of tobacco.

Authors:  S K Ng; G C Kabat; E L Wynder
Journal:  J Natl Cancer Inst       Date:  1993-05-05       Impact factor: 13.506

3.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

Review 4.  The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.

Authors:  Stephen Caldwell; Sang H Park
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

5.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.

Authors:  Ulf Klein; Marie Lia; Marta Crespo; Rachael Siegel; Qiong Shen; Tongwei Mo; Alberto Ambesi-Impiombato; Andrea Califano; Anna Migliazza; Govind Bhagat; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2010-01-07       Impact factor: 31.743

8.  Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.

Authors:  Annika Brendle; Haixin Lei; Andreas Brandt; Robert Johansson; Kerstin Enquist; Roger Henriksson; Kari Hemminki; Per Lenner; Asta Försti
Journal:  Carcinogenesis       Date:  2008-06-10       Impact factor: 4.944

9.  A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.

Authors:  Sandrine Tchatchou; Anke Jung; Kari Hemminki; Christian Sutter; Barbara Wappenschmidt; Peter Bugert; Bernhard H F Weber; Dieter Niederacher; Norbert Arnold; Raymonda Varon-Mateeva; Nina Ditsch; Alfons Meindl; Rita K Schmutzler; Claus R Bartram; Barbara Burwinkel
Journal:  Carcinogenesis       Date:  2008-11-20       Impact factor: 4.944

10.  MicroTar: predicting microRNA targets from RNA duplexes.

Authors:  Rahul Thadani; Martti T Tammi
Journal:  BMC Bioinformatics       Date:  2006-12-18       Impact factor: 3.169
View more
  23 in total

1.  Association of KLK3, VAMP8 and MDM4 Genetic Variants within microRNA Binding Sites with Prostate Cancer: Evidence from Serbian Population.

Authors:  Nevena Kotarac; Zorana Dobrijevic; Suzana Matijasevic; Dusanka Savic-Pavicevic; Goran Brajuskovic
Journal:  Pathol Oncol Res       Date:  2020-06-17       Impact factor: 3.201

2.  Effects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis.

Authors:  D Wan; W Gu; G Xu; C Shen; D Ding; S Shen; S Wang; X Gong; S He; Q Zhi
Journal:  Clin Transl Oncol       Date:  2014-01-08       Impact factor: 3.405

3.  Principles for the post-GWAS functional characterization of cancer risk loci.

Authors:  Matthew L Freedman; Alvaro N A Monteiro; Simon A Gayther; Gerhard A Coetzee; Angela Risch; Christoph Plass; Graham Casey; Mariella De Biasi; Chris Carlson; David Duggan; Michael James; Pengyuan Liu; Jay W Tichelaar; Haris G Vikis; Ming You; Ian G Mills
Journal:  Nat Genet       Date:  2011-06       Impact factor: 38.330

Review 4.  Cancer microRNAs: from subtype profiling to predictors of response to therapy.

Authors:  Elcie Chan; Daniel Estévez Prado; Joanne Barnes Weidhaas
Journal:  Trends Mol Med       Date:  2011-02-25       Impact factor: 11.951

5.  MicroRNA signatures differentiate melanoma subtypes.

Authors:  Elcie Chan; Rajeshvari Patel; Sunitha Nallur; Elena Ratner; Antonella Bacchiocchi; Kathleen Hoyt; Sebastian Szpakowski; Sirie Godshalk; Stephan Ariyan; Mario Sznol; Ruth Halaban; Michael Krauthammer; David Tuck; Frank J Slack; Joanne Barnes Weidhaas
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

6.  A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population.

Authors:  Hasan Raza Kazmi; Abhijit Chandra; Saket Kumar; Leena Khare Satyam; Annapurna Gupta; Jaya Nigam; Meenu Srivastava; Balraj Mittal
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

7.  In silico analysis of polymorphisms in microRNAs that target genes affecting aerobic glycolysis.

Authors:  Padmanaban S Suresh; Thejaswini Venkatesh; Rie Tsutsumi
Journal:  Ann Transl Med       Date:  2016-02

8.  A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer.

Authors:  Shane Stegeman; Ernest Amankwah; Kerenaftali Klein; Tracy A O'Mara; Donghwa Kim; Hui-Yi Lin; Jennifer Permuth-Wey; Thomas A Sellers; Srilakshmi Srinivasan; Rosalind Eeles; Doug Easton; Zsofia Kote-Jarai; Ali Amin Al Olama; Sara Benlloch; Kenneth Muir; Graham G Giles; Fredrik Wiklund; Henrik Gronberg; Christopher A Haiman; Johanna Schleutker; Børge G Nordestgaard; Ruth C Travis; David Neal; Paul Pharoah; Kay-Tee Khaw; Janet L Stanford; William J Blot; Stephen Thibodeau; Christiane Maier; Adam S Kibel; Cezary Cybulski; Lisa Cannon-Albright; Hermann Brenner; Radka Kaneva; Manuel R Teixeira; Amanda B Spurdle; Judith A Clements; Jong Y Park; Jyotsna Batra
Journal:  Cancer Discov       Date:  2015-02-17       Impact factor: 39.397

9.  Cross-mapping events in miRNAs reveal potential miRNA-mimics and evolutionary implications.

Authors:  Li Guo; Tingming Liang; Wanjun Gu; Yuming Xu; Yunfei Bai; Zuhong Lu
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

10.  Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neck.

Authors:  Hongping Yu; Zhensheng Liu; Yu-Jing Huang; Ming Yin; Li-E Wang; Qingyi Wei
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.